Recent Updates
Recently added Catalysts
ADMA Negative Sentiment Score: 35/100

ADMA Investor News: If You Have Suffered Losses in ADMA Biologics, Inc. (NASDAQ: ADMA), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

Key Takeaway: The Rosen Law Firm is investigating potential securities claims on behalf of shareholders of ADMA Biologics, Inc. following allegations of misleading business information. The investigation comes after ADMA's stock dropped 16.6% on March 24, 2026, due to a report claiming the company engaged in channel stuffing. Investors who purchased shares may be eligible for compensation through a proposed class action, for which the law firm is seeking participants.

Market Sentiment Analysis

CONCERNS & RISKS

  • ADMA Biologics faced allegations of issuing misleading business information to investors.
  • The company's stock fell 16.6% due to claims of channel stuffing to inflate revenue.
  • A class action has been initiated against ADMA Biologics due to investor losses.

Full Press Release Details

NEW YORK, May 19, 2026 (GLOBE NEWSWIRE) --
WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of ADMA Biologics, Inc. (NASDAQ: ADMA) resulting from allegations that ADMA Biologics may have issued materially misleading business information to the investing public.
SO WHAT: If you purchased ADMA Biologics securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. The Rosen Law Firm is preparing a class action seeking recovery of investor losses.
WHAT TO DO NEXT: To join the prospective class action, go to https://rosenlegal.com/submit-form/?case_id=57940 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email case@rosenlegal.com for information on the class action.
WHAT IS THIS ABOUT: On March 24, 2026, Investing.com published an article entitled “ADMA Biologics shares plunge on short seller allegations.” The article stated that ADMA Biologics shares fell “after short seller Culper Research released a report alleging the company engaged in channel stuffing to inflate revenue growth.”
On this news, ADMA Biologics stock fell 16.6% on March 24, 2026.
WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved, at that time, the largest ever securities class action settlement against a Chinese Company. At the time Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.
Attorney Advertising. Prior results do not guarantee a similar outcome.
Contact Information:
Laurence Rosen, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
Toll Free: (866) 767-3653

Tags

Frequently Asked Questions

What is the investigation involving ADMA Biologics about?

Rosen Law Firm is investigating potential securities claims against ADMA Biologics due to allegations of misleading business information.

How can shareholders of ADMA Biologics join the class action?

Shareholders can join the class action by visiting the Rosen Law Firm's website or contacting Phillip Kim via phone or email.

What caused ADMA Biologics stock to drop significantly?

ADMA Biologics shares fell 16.6% following a report from Culper Research alleging the company engaged in channel stuffing.

Why choose Rosen Law Firm for representation?

Rosen Law Firm has a strong track record in securities class actions and has recovered substantial sums for investors.

Last updated: May 20, 2026